MAPT and Alzheimer disease: Palleis et al. (247) compared patients with CBS having underlying AD, based on amyloid-PET imaging, and non-AD tau and suggested that higher dorsolateral prefrontal cortical binding of this tracer may differentiate AD-CBS from tau-CBS.